54 The epidermal growth factor receptor tyrosine kinase inhibitor, eriotinib (Tarceva TM, OSI-774), is an active agent in bronchioloalveolar carcinoma (BAC) and its variants: interim results of a phase II trial
2003 ◽
Vol 1
(5)
◽
pp. S21
◽
2003 ◽
Vol 94
(5)
◽
pp. 453-458
◽
2005 ◽
Vol 23
(2)
◽
pp. 165-170
◽
2020 ◽
2014 ◽
Vol 35
(8)
◽
pp. 915
2021 ◽
2005 ◽
Vol 11
(4)
◽
pp. 1572-1578
◽
2014 ◽
Vol 21
(S4)
◽
pp. 610-618
◽